• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK details
Primary information
ID antitb_1738,
NameUS 2012/0197004
N-Terminal modificationFKAB-1G
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationAcetylation
Linear/CyclicAmidation
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginHydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae
Cell LineMIC = 10 μM
Inhibition ConcentrationBoth
Sequence2012
CytotoxicityRBC
In vivo ModelNA
Lethal Dose14 % hemolysis at 100 and 25 μM
Immune ResponceMice
Mechanism of ActionNo observed toxicity at 5 and 25 mg/kg but minor
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNone
Year of PublicationAnti-bacterial (Salmonella typhimurium, Staphylococcus aureus, Bacillus subtillis)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1739,
NameUS 2012/0197004
N-Terminal modificationFKAB-1H
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationAcetylation
Linear/CyclicAddition of CONH-CH2-CH2-NH2
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginHydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae
Cell LineMIC = 10 μM
Inhibition ConcentrationBoth
Sequence2012
CytotoxicityRBC
In vivo ModelNA
Lethal DoseNA
Immune ResponceMice
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNone
Year of PublicationAnti-bacterial (Salmonella typhimurium, Staphylococcus aureus, Bacillus subtillis)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1740,
NameUS 2012/0197004
N-Terminal modificationFKAB-1L
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationAcetylation
Linear/CyclicAddition of CONH-CH2-CH2-CH2-NH2
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginHydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae
Cell LineMIC = 10 μM
Inhibition ConcentrationBoth
Sequence2012
CytotoxicityRBC
In vivo ModelNA
Lethal DoseNA
Immune ResponceMice
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNone
Year of PublicationAnti-bacterial (Salmonella typhimurium, Staphylococcus aureus, Bacillus subtillis)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1779,
Name17547385
N-Terminal modificationPeptide-23
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationAcetylation
Linear/CyclicAmidation
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginAmphipathic, Hydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae (ATCC 110)
Cell LineMIC = 10 µM or 24 µg/mL
Inhibition ConcentrationBoth
Sequence2007
CytotoxicityRBC
In vivo ModelNA
Lethal Dose14 % hemolytic activity at 100 µM peptide
Immune Responcemouse skin wound healing model
Mechanism of ActionAcute toxicity was observed at dose of 125 mg/kg
TargetStimulate innate immune system
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationAntibacterial (Salmonella typhimurium (ATCC 13311), Staphylococcus aureus methicillin/gentamicin/tetrac+AB20ycline resistant (ATCC 33592), Bacillus subtillis (ATCC 43223))
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1780,
Name17547385
N-Terminal modificationPeptide-24
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationAcetylation
Linear/CyclicAddition of -CONH-CH2-CH2-NH2
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginAmphipathic, Hydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae (ATCC 110)
Cell LineMIC = 10 µM or 25 µg/mL
Inhibition ConcentrationBoth
Sequence2007
CytotoxicityNA
In vivo ModelNA
Lethal DoseNot tested
Immune ResponceNA
Mechanism of ActionNA
TargetStimulate innate immune system
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationAntibacterial (Salmonella typhimurium (ATCC 13311), Staphylococcus aureus methicillin/gentamicin/tetrac+AB20ycline resistant (ATCC 33592), Bacillus subtillis (ATCC 43223))
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1781,
Name17547385
N-Terminal modificationPeptide-25
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationAcetylation
Linear/CyclicAddition of CONH-CH2-CH2-CH2-NH2
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginAmphipathic, Hydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae (ATCC 110)
Cell LineMIC = 10 µM or 25 µg/mL
Inhibition ConcentrationBoth
Sequence2007
CytotoxicityNA
In vivo ModelNA
Lethal DoseNot tested
Immune ResponceNA
Mechanism of ActionNA
TargetStimulate innate immune system
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationAntibacterial (Salmonella typhimurium (ATCC 13311), Staphylococcus aureus methicillin/gentamicin/tetrac+AB20ycline resistant (ATCC 33592), Bacillus subtillis (ATCC 43223))
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1782,
Name17547385
N-Terminal modificationPeptide-26
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationFree
Linear/CyclicAmidation
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginAmphipathic, Hydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae (ATCC 110)
Cell LineMIC = 10 µM or 24 µg/mL
Inhibition ConcentrationBoth
Sequence2007
CytotoxicityRBC
In vivo ModelNA
Lethal Dose33.4 % and 14.3% hemolytic activity at 100 µM and 25 µM peptide respectively
Immune ResponceNA
Mechanism of ActionNA
TargetStimulate innate immune system
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationAntibacterial (Salmonella typhimurium (ATCC 13311), Staphylococcus aureus methicillin/gentamicin/tetrac+AB20ycline resistant (ATCC 33592), Bacillus subtillis (ATCC 43223))
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1800,
Name17547385
N-Terminal modificationPeptide-44
C-Terminal ModificationGF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK
Chemical ModificationBiotinylation
Linear/CyclicAmidation
LengthTic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginAmphipathic, Hydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae (ATCC 110)
Cell LineMIC = 10 µM or 26 µg/mL
Inhibition ConcentrationBoth
Sequence2007
CytotoxicityNA
In vivo ModelNA
Lethal DoseNot tested
Immune ResponceNA
Mechanism of ActionNA
TargetStimulate innate immune system
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationAntibacterial (Salmonella typhimurium (ATCC 13311), Staphylococcus aureus methicillin/gentamicin/tetrac+AB20ycline resistant (ATCC 33592), Bacillus subtillis (ATCC 43223))
Tertiary Structure
(Technique)
Not Predicted),